Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center in Relation to Complementary and Alternative Medicine
暂无分享,去创建一个
M. Lux | M. Beckmann | P. Fasching | L. Häberle | S. Jud | C. Loehberg | A. Hein | C. Hack | M. Wunderle | Julia Meyer | J. Emons | P. Gass | Sonja Wasner | Sainab Egloffstein
[1] M. Lux,et al. Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center , 2020, Archives of Gynecology and Obstetrics.
[2] M. Lux,et al. Update Breast Cancer 2019 Part 4 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer , 2019, Geburtshilfe und Frauenheilkunde.
[3] M. Lux,et al. Update Breast Cancer 2019 Part 5 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer , 2019, Geburtshilfe und Frauenheilkunde.
[4] M. Lux,et al. Update Breast Cancer 2019 Part 3 – Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel , 2019, Geburtshilfe und Frauenheilkunde.
[5] M. Lux,et al. Update Breast Cancer 2019 Part 1 – Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer , 2019, Geburtshilfe und Frauenheilkunde.
[6] M. Lux,et al. Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice , 2019, Geburtshilfe und Frauenheilkunde.
[7] C. Witt,et al. A Comprehensive Definition for Integrative Oncology. , 2017, Journal of the National Cancer Institute. Monographs.
[8] D. Pieper,et al. [Limited Data for Second Opinion Programs: a Systematic Review]. , 2017, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).
[9] U. Tirelli,et al. Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey , 2016, Oncotarget.
[10] D. Ruetters,et al. Is there evidence for a better health care for cancer patients after a second opinion? A systematic review , 2016, Journal of Cancer Research and Clinical Oncology.
[11] M. Beckmann,et al. A Review of Integrative Medicine in Gynaecological Oncology , 2016, Geburtshilfe und Frauenheilkunde.
[12] R. Kreienberg,et al. Quality of care in breast cancer centers: results of benchmarking by the German Cancer Society and German Society for Breast Diseases. , 2015, Breast.
[13] C. Pforr,et al. The legacy of Sebastian Kneipp: linking wellness, naturopathic, and allopathic medicine. , 2014, Journal of alternative and complementary medicine.
[14] A. Hein,et al. Klassische Naturheilverfahren nach Kneipp in der Gynäkologie und Geburtshilfe , 2014, Frauenheilkunde up2date.
[15] L. Weeks,et al. A systematic review of integrative oncology programs. , 2012, Current oncology.
[16] M. Zwahlen,et al. How Many Cancer Patients Use Complementary and Alternative Medicine , 2012, Integrative cancer therapies.
[17] J. Harrigan. Patient disclosure of the use of complementary and alternative medicine to their obstetrician/gynaecologist , 2011, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[18] C. Wittekind. [2010 TNM system: on the 7th edition of TNM classification of malignant tumors]. , 2010, Der Pathologe.
[19] M. Jefford,et al. Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. , 2010, Patient education and counseling.
[20] Jason Goh. Quality of care. , 2010, Clinical medicine.
[21] P. Cleary,et al. Perceptions of cancer‐related information among cancer survivors: A report from the American Cancer Society's Studies of Cancer Survivors , 2008, Cancer.
[22] J. Pierce,et al. Disclosure to Physicians of CAM Use by Breast Cancer Patients: Findings From the Women's Healthy Eating and Living Study , 2008, Integrative cancer therapies.
[23] W. Schmiegel,et al. Onkologie. 3-Stufen-Modell optimiert Behandlung unter Kostendeckung. Wie die künftigen Strukturen der onkologischen Versorgung in Deutschland aussehen sollten , 2008 .
[24] S. Bauer-Wu,et al. Prevalence and predictors of complementary therapy use in advanced-stage breast cancer patients. , 2007, Journal of oncology practice.
[25] Julia A Scott,et al. Complementary and alternative medicine use in breast cancer patients in Europe , 2006, Supportive Care in Cancer.
[26] Julia A Scott,et al. Use of complementary and alternative medicine in cancer patients: a European survey. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] E. Swisher,et al. Use of complementary and alternative medicine among women with gynecologic cancers. , 2002, Gynecologic oncology.
[28] E. Jenison,et al. A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients , 2001, International Journal of Gynecologic Cancer.
[29] J. Siewert,et al. ["Second opinion"--attempt at establishing a definition]. , 1996, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[30] W. Jungi,et al. [Why do cancer patients use alternative medicine?]. , 1991, Schweizerische medizinische Wochenschrift.
[31] M. Lux,et al. [Resilience, Fear of Progression and Psychosocial Distress in Patients with Breast Cancer and Gynecological Tumors Seeking a Second Opinion]. , 2018, Psychotherapie, Psychosomatik, medizinische Psychologie.
[32] M. Beckmann,et al. The concept of the certification system of the German Cancer Society and its impact on gynecological cancer care , 2013, Archives of Gynecology and Obstetrics.
[33] K. Münstedt,et al. Unconventional cancer therapy —survey of patients with gynaecological malignancy , 2004, Archives of Gynecology and Obstetrics.